ReleaseWire Connect

Latest industry research report on Anterior Uveitis Market. Anterior uveitis is an eye inflammation that involves middle layer of the eye specifically, iris (colored part of the eye) and ciliary body (adjacent tissue). Untreated anterior uveitis results in loss of vision and permanent eye damage that arises with the development of infections such as glaucoma, retinal edema or cataract. Anterior uveitis can be treated with eye drops containing anti-inflammatory drugs. It usually responds well to treatment. However, there may be a tendency of the condition to re-occur. Uveitis remains a less-explored research indication that involves diverse therapeutics as treatment options including corticosteroids and biologics.

Latest industry research report on RNA-Based Therapeutics Market. The RNA-based therapeutics involves broad range of the RNA-based technologies, which help the patients to diagnose or treat various chronic diseases. The RNA-based therapeutics plays a crucial role in providing the accurate and precise healthcare treatments, which helps in treating the disease at molecular and sub-molecular levels. RNA-based therapeutic modalities provide beneficial business opportunities due to its rising acceptance, technological advancements and targeted drug delivery of these therapeutics as compared to the other treatment modalities (synthetic therapeutics). The Asia-Pacific RNA-based therapeutics market is growing at a promising CAGR due to the gene silencing potential of this therapeutics.

Latest industry research report on Colonoscopy Devices Market. The Asian colonoscopy devices market is witnessing growth owing to the increase in the investments by several government bodies. The government organizations are now providing grants and funds to create awareness among mass population about minimum invasive surgeries. However, lack of trained physicians as well as uncertain reimbursement conditions has hindered the market growth. In addition, growing geriatric populations as well as technological developments are expected to create greater opportunities.

Latest industry research report on Hormone Refractory Breast Cancer Market. Breast cancer is the most common type of malignant cancer prevalent in women above the age of 40. Cancer is the most fatal human disease accounting for the deaths of ~8.2 million people worldwide in 2012. Among these deaths, breast cancer was found to be most prominent disease among women that killed ~521,000 individuals. Presently, increasing number of hormone therapies have made refractory breast cancers resistant toward therapeutics, termed as hormone-resistant breast cancers. However, recently developed hormone refractory breast cancer chemotherapeutic agents such as, trastuzumab and everolimus, alone or in combination, are under clinical trials for the effective treatment of hormone refractory breast cancers.

Latest industry research report on Peripheral Intervention Devices Market. Peripheral intervention devices are used to treat the peripheral artery diseases by performing minimal invasive surgeries. These devices makes the minute incisions in the body parts to removes the plaque blockages in the arteries and other vessel walls of peripheral organ which includes kidneys, brain and lower extremities. The different devices used for peripheral intervention procedures includes balloons, stent grafts, plaque modification devices, angiography catheters, hemodynamic flow alteration (HFA) devices and other accessory devices. Increasing acceptance of minimally invasive peripheral intervention surgeries due to its associated benefits such as reduced discomfort, short recovery time, less bleeding, minimum scars and reduced hospital durations are driving the Asia pacific market for peripheral intervention devices.

Latest industry research report on Peripheral Intervention Market. Peripheral intervention procedures are minimal invasive surgeries performed to remove plaques, which is a root cause of several diseases related to peripheral artery. Peripheral intervention surgeries are performed to restore the blood flow of the arteries. They are also used to remove clotting that prevents the flow of oxygenated blood. The increasing aging population and rising prevalence of heart diseases are augmenting the growth of peripheral intervention market in Asia-Pacific region. Moreover, technological innovations, shifting healthcare dynamics and growing clinical experiences are further driving the growth of peripheral intervention market in this region.

Latest industry research report on Continuous Glucose Monitoring Market. Rise in incidence of diabetes across the globe has elevated the need of innovative diabetic management devices, which has increased the adoption of continuous glucose monitoring (CGM) devices. The existing glucose monitoring devices have few gaps that are bridged by the innovative CGM. With CGM, significant improvement has been observed in stabilizing the elevated A1C levels, which in turn reduced the risk of developing long-term diabetic complications. Driving factors for the CGM market are technological innovation in the form of artificial pancreas and increasing awareness among Asia-Pacific countries such as India, China, Japan and others.

Latest industry research report on Sexually Transmitted Diseases Testing Market. Sexually Transmitted Diseases (STDs) are also known as Venereal Diseases (VDs) or Sexually Transmitted Infections (STIs). A variety of methods have been employed for the diagnosis of STDs that differ based on the type of disease. The objective of this report is to provide an in-depth understanding of diagnostic tests of STDs. Rising incidences of fatal STDs, corresponding high-economic burden and consequent implementation of Provider-Initiated Counseling and Testing (PICT) and Client-Initiated Counseling and Testing (CICT) drive the growth of STD testing market.

New report on Organ Transplant Immunosuppressant Drugs are the category of drugs which are administered to minimize the chances of organ rejection after transplantation. When a person undergoes any transplantation, the body recognizes the transplant as a foreign tissue and attacks it, resulting in rejection. These drugs dilute the immune system, hence reducing the reaction towards the transplant. The factors driving this market include the advancements made in tissue engineering and organ transplantations. These transplantations help in survival of many patients as well as enhance the quality of life. The lack of availability of organs and high cost of transplantation are the limitations for the growth of this market. The increase in use of tissue engineering for generation of implants provides growth opportunity to this market.

New report on Large Volume Parenteral (LVP) preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body. Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use. The factors driving this market include increasing hospitalization rate and rise in demand for faster, safer and effective administration of drugs. The introduction of single dosage nervous system disorders, oncology and diabetes would provide opportunities for growth of this market.